跳至主要内容
临床试验/NCT07336966
NCT07336966尚未招募不适用

Does Recessive Optic Atrophy Due to WFS1 is a Specific Entity Different From Wolfram Syndrome?

Hôpital Necker-Enfants Malades0 个研究点目标入组 45 人开始时间: 2026年2月1日最近更新:
干预措施

试验速览

阶段
不适用
状态
尚未招募
发起方
入组人数
45
主要终点
Visual acuity at the last visit

研究概览

简要总结

All patients with Wolfram syndrome and recessive optic atrophy due to a mutation of the WFS1 from a single Center were included in a retrospective study. Evolution of the visual acuity since the occurrence of the optic atrophy and its last value, OCT data, genetic data and systemic manifestations were analyzed.

详细描述

Ophthalmological date will be include : farsighted best corrected visual acuity (BCVA) assessment, slit-lamp examination of the anterior segment, Goldman aplanation tonometry, funduscopy, retinography, Goldman manual visual field and optical coherent tomography (OCT). These will include global value of Retinal Nerve Fiber Layer (RNFL) thickness as well as the ganglion cell complex (GCC) thickness.

研究设计

研究类型
Observational
观察模型
Case Control
时间视角
Retrospective

入排标准

性别
All
接受健康志愿者

入选标准

  • WFS1 mutation

排除标准

  • WFS2 mutation

研究组 & 干预措施

wolfram syndrome

Patients according to the EuroWABB criterions of Wolfram syndrome and French national guidelines

干预措施: analyse study (Other)

recessive optic atrophy

patients with an OA due to mutation of gene WFS1, whatever its age of occurrence, without any other clinical manifestation.

干预措施: analyse study (Other)

结局指标

主要结局

Visual acuity at the last visit

时间窗: The last visit will be registered regardless of the time elapsed since the onset of the disease, considered as a baseline

Comparison of visual acuity at the last visual between the 2 groups

次要结局

  • Evolution of visual acuity(Measurement at the occurence of the disease considered as baseline and at the last visit)
  • Age(At the occurence of the disease considered as baseline)
  • Global RNFL thickness(Measurement at the occurence of the disease considered as baseline and at the last visit)

研究者

发起方
Hôpital Necker-Enfants Malades
申办方类型
Other
责任方
Principal Investigator
主要研究者

Christophe Orssaud

MD, Responsible CRMR Ophtara HEGP

European Georges Pompidou Hospital

相似试验